Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Nam H.K. Nguyen"'
Autor:
Nam H.K. Nguyen, Abderrahmane Tagmount, Jeffrey E. Rubnitz, Raul C. Ribeiro, Xueyuan Cao, Stanley B. Pounds, Chris D. Vulpe, Jatinder K. Lamba
Publikováno v:
Blood. 140:5947-5948
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c4c102d26ba2c4e125ad521583aca8b
https://doi.org/10.1182/blood-2022-159322
https://doi.org/10.1182/blood-2022-159322
Autor:
Junmin Peng, Haiyan Tan, Xueyuan Cao, Jatinder K. Lamba, Huiyun Wu, Stanley Pounds, Nam H.K. Nguyen, Jeffrey E. Rubnitz
Publikováno v:
Cancers, Vol 13, Iss 3161, p 3161 (2021)
Cancers
Volume 13
Issue 13
Cancers
Volume 13
Issue 13
Acute Myeloid Leukemia (AML) is a heterogeneous disease with several recurrent cytogenetic abnormalities. Despite genomics and transcriptomics profiling efforts to understand AML’s heterogeneity, studies focused on the proteomic profiles associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bf10cd457004ed5395f2f51833ed2d5
https://www.mdpi.com/2072-6694/13/13/3161
https://www.mdpi.com/2072-6694/13/13/3161
Autor:
Jenica N. Upshaw, Michael G. Fradley, Yiqing Chen, Yan Gong, Bonnie Ky, Avirup Guha, Nam H.K. Nguyen
Publikováno v:
Circulation. 142
Introduction: Cyclin Dependent Kinase (CDK) 4/6 inhibitors are a novel class of cancer therapeutics which have significantly improved survival in patients with hormone receptor positive, HER2 negative metastatic breast cancer. There is little data re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee2dc428f3fa2d2bad366d7189b6b632
https://doi.org/10.1161/circ.142.suppl_3.16720
https://doi.org/10.1161/circ.142.suppl_3.16720
Autor:
Michael G. Fradley, Taimour Y. Langaee, Yan Gong, Carl J. Pepine, Yiqing Chen, David L. DeRemer, Rhonda M. Cooper-DeHoff, Faraz S. Ahmad, Nam H.K. Nguyen, Nida Waheed
Publikováno v:
Circulation. 142
Introduction: Anthracyclines remain a key treatment for many malignancies but can increase the risk of heart failure or cardiomyopathy. Different guidelines recommend echocardiography (echo) and BNP or NT-proBNP evaluation before and 6-12 months afte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa7be35b16a691a4a9eafb6a27430fda
https://doi.org/10.1161/circ.142.suppl_3.16457
https://doi.org/10.1161/circ.142.suppl_3.16457
Autor:
Reema Kashif, Vivek M. Shastri, Jatinder K. Lamba, Nam H.K. Nguyen, Roya Rafiee, Biljana Horn, Karna Mangrola, Trisha Larkin, Abdelrahman H Elsayed, Natasha Emanuel
Publikováno v:
Blood. 138:3360-3360
Introduction: Despite cure rates in acute lymphoblastic leukemia (ALL) exceeding 90% in clinical trials, morbidity due to drug toxicities is high. Genetic polymorphisms can influence gene expression and activity, impacting pharmacokinetics and causin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::536c755f4c97f27c5e370ee4da0f5c57
https://doi.org/10.1182/blood-2021-151357
https://doi.org/10.1182/blood-2021-151357
Autor:
Ying Lu, Biljana Horn, Jatinder K. Lamba, Janel Long-Boyle, Beth Apsel Winger, Nam H.K. Nguyen, Vivek M. Shastri
Publikováno v:
Blood. 138:908-908
Introduction: Total Body Irradiation (TBI) conditioning regimens are considered standard of care for pediatric hematopoietic cell transplant (HCT) recipients. However, TBI has many long-term effects, so avoiding it in young HCT recipients is critical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b7d6c52975668123be5fa283923d55f
https://doi.org/10.1182/blood-2021-151457
https://doi.org/10.1182/blood-2021-151457
Autor:
Junmin Peng, Jeffrey E. Rubnitz, Jatinder K. Lamba, Huiyun Wu, Stanley Pounds, Nam H.K. Nguyen
Publikováno v:
Cancer Research. 81:2535-2535
Introduction: Acute Myeloid Leukemia (AML) is a heterogeneous disease with cytogenetic abnormalities and gene mutations that are routinely used in clinical practice to stratify patients into three risk groups: low, intermediate, or high. Core binding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20e7f3e5ab1c70a6f5a72a7a52538a07
https://doi.org/10.1158/1538-7445.am2021-2535
https://doi.org/10.1158/1538-7445.am2021-2535
Publikováno v:
Blood. 136:7-7
Introduction: Ara-C (cytarabine), daunorubicin, and etoposide (ADE) remain key chemotherapies used in remission induction and consolidation therapy of pediatric acute myeloid leukemia (pAML). However, multiple drug resistance is a major cause of ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0260a6d53a878010456f50cebe8dd4b
https://doi.org/10.1182/blood-2020-139030
https://doi.org/10.1182/blood-2020-139030